| Abstract: |
The digital personalized medicine system uses digital data to assess or diagnose symptoms of a subject to provide personalized or more appropriate therapeutic interventions and improved diagnoses. The use of prioritized questions and answers with associated feature importance can be used to assess mental function and allow a subject to be diagnosed with fewer questions, such that diagnosis can be repeated more often and allow the dosage to be adjusted more frequently. Pharmacokinetics of the subject can be estimated based on demographic data and biomarkers or measured, in order to determine a treatment plan for the subject. Also, biomarkers can be used to determine when the patient may be at risk for experiencing undesirable side effects and the treatment plan adjusted accordingly. |
| Inventor: |
VAUGHAN, Brent (Portola Valley, CA, US) |
| Applicant: |
Cognoa, Inc. (Palo Alto, CA, US) |
| Face Assignee: |
N/A |
| Filed: |
2018-10-09 |
| Issued: |
2019-02-07 |
| Claims: |
20 |
|
US20190043610
|
1. A computer-implemented method for providing an individual with a personal therapeutic treatment plan for treating a disorder, delay, or impairment, said method comprising:
(10)
(2)
|
|
